Abstract:<p>Glycyrrhetinic acid monoglucuronide (GAMG) is an innovative functional sweetener with higher sweetness and stronger pharmacological activity than glycyrrhizin (GL). A novel β-glucuronidase (cg-GUS) was firstly screened from plant endophytic fungus <em>Chaetomium globosum</em> DX-THS3. The cg-GUS demonstrated the specify and highly transform glycyrrhizin (GL) to generate GAMG, and the maximum activity of β-glucuronidase at 45 °C and pH 6.0, displaying excellent thermostability and pH-stability. The K<sub>m</sub> and V<sub>max</sub> values of cg-GUS were 0.134 mM and 236.42 mM/min/mg, respectively, which showed the high chemical bond selectivity and biotransformation efficiency of cg-GUS. Meanwhile, the <em>cg-GUS</em> gene (1896 bp) was analyzed, and Gly-345, Ser-539, Gly-563, Ala-579, Ser-581 and Glu-619 in GH2 catalytic domain of cg-GUS are potential mutation position for result in high-efficient and substrate-specify of cg-GUS. Our results were indicated that cg-GUS is a biocatalyst for production of GAMG and potent application in food and medicinal industry.</p>
What problem does this paper attempt to address?
### What problem does this paper attempt to solve?
This paper aims to solve the problem of the efficient conversion of glycyrrhizic acid (GL) into glycyrrhetinic acid monoglucuronide (GAMG). Specifically, the author screened and purified a new type of β - glucuronidase (cg - GUS) from endophytic fungi in plants. This enzyme can specifically and efficiently convert glycyrrhizic acid (GL) into glycyrrhetinic acid monoglucuronide (GAMG) without further hydrolysis into glycyrrhetinic acid (GA). This conversion process has important economic and application values because GAMG not only has a higher sweetness and stronger pharmacological activity than GL, but also has higher safety.
#### Main research background and problems
1. **Market demand and challenges**:
- Licorice extract is widely used as a natural sweetener, drug, and dietary supplement.
- Glycyrrhizic acid (GL) is the main bioactive component of licorice extract, but its hydrolysis product, glycyrrhetinic acid monoglucuronide (GAMG), has a higher sweetness (about 1,000 times sweeter than sucrose) and stronger physiological characteristics.
- GAMG has broad application prospects in the food and pharmaceutical industries, but the existing chemical and biological hydrolysis methods have problems such as poor selectivity and harsh conditions, which limit large - scale production.
2. **Limitations of existing methods**:
- Chemical hydrolysis methods usually have poor selectivity and require harsh conditions such as strong acids or high temperatures, resulting in environmental pollution.
- Although the biotransformation method has high yield, high selectivity, and environmental friendliness, most of the known β - glucuronidases (GUS) have low hydrolysis selectivity for GL and are easily further hydrolyzed into glycyrrhetinic acid (GA), thus reducing the yield of GAMG.
3. **Research objectives**:
- Screen and purify a new type of β - glucuronidase (cg - GUS) that can specifically and efficiently convert GL into GAMG without further hydrolysis into GA.
- Study the catalytic characteristics, thermal stability, and pH stability of this enzyme, and analyze its gene sequence to provide a basis for further applications.
#### Research content
1. **Screening and purification of cg - GUS**:
- A new type of β - glucuronidase (cg - GUS) was screened and purified from the endophytic fungus *Chaetomium globosum DX - THS3* in plants.
- The optimum temperature, pH value, substrate specificity, and catalytic efficiency of this enzyme were studied.
2. **Analysis of enzymatic properties**:
- The Michaelis constant (\( K_m \)) and the maximum reaction rate (\( V_{max} \)) of cg - GUS were determined to be 0.134 mM and 236.42 mM/min/mg, respectively.
- The cg - GUS gene sequence was analyzed, and it was found that several amino acid sites in its GH2 catalytic domain (such as Gly - 345, Ser - 539, Gly - 563, Ala - 579, Ser - 581, and Glu - 619) may be the key mutation sites for improving enzyme activity and substrate selectivity.
3. **Application potential**:
- As an efficient biocatalyst, cg - GUS can be used for GAMG production in the food and pharmaceutical industries.
- The research results show that cg - GUS has excellent catalytic performance and stability under mild conditions and is expected to become an ideal enzyme source for industrial production of GAMG.
Through the above research, the author has successfully solved the problem of poor selectivity in the conversion process from GL to GAMG in existing methods, providing new ideas and technical support for the development of efficient GAMG production processes.